Beckman Coulter Life Sciences has unveiled a groundbreaking innovation in allergy research with the release of its next-generation Basophil Activation Test (BAT), designed exclusively for research use. This powerful assay enables precise characterization of food allergies via a standard blood draw—eliminating the need for risky oral food challenges.

This test leverages proprietary dry technology, integrating allergens and conjugated antibodies in a single-tube format. By drastically simplifying the traditional BAT process, it ensures consistency and reproducibility across laboratories. Compatibility with all flow cytometers and the elimination of centrifugation and compensation further enhance its accessibility.

Key Features of the Next-Gen BAT for Researchers

• Dry technology with pre-mixed antibodies and allergens in a single tube

• Only four pipetting steps required for execution

• No centrifugation or compensation needed

• Built-in controls for enhanced assay standardization

• Compatible with all flow cytometers

• Enables multiplex allergen testing via a single blood sample

This innovation marks a significant shift toward safer, faster, and more reproducible food allergy research—streamlining processes and supporting future clinical applications.